Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia

1993211 citationsJournal Article

Authors

H.Y. Meltzer · Case Western Reserve University

Philip A. Cola

Abstract

Clozapine is a cost-effective treatment for treatment-resistant schizophrenic patients. Cost savings result almost exclusively from the reduced cost of hospitalization.

Topics & Keywords

Schizophrenia research and treatment Mental Health and Psychiatry Bipolar Disorder and Treatment

UN Sustainable Development Goals

No poverty

Publication Details

Published in: American Journal of Psychiatry

Volume 150, Issue 11, pp. 1630-1638

DOI: 10.1176/ajp.150.11.1630

Field-Weighted Citation Impact: 13.44